azepane-2-carboxylic acid ethyl ester | 2886-92-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: azepane-2-carboxylic acid ethyl ester
• 英文别名: Ethyl azepane-2-carboxylate
• CAS: 2886-92-2
• 化学式: C₉H₁₇NO₂
• mdl: MFCD00296947
• 分子量: 171.239
• InChiKey: SEPAWPFHCJAZRG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.888
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  azepane-2-carboxylic acid ethyl ester 以87%的产率得到
  参考文献：
  名称：

  LIXOSHERSTOV A. M.; KRITSYN A. M.; MESHCHERYAKOVA M. B.; LEBEDEVA A. S.; +, XIM.-FARMATSEVT. ZH., 1978, 12, HO 4, 58-62

  摘要：

  DOI：

文献信息

• Thrombin inhibitors. 3. Carboxyl-containing amide derivatives of N.alpha.-substituted L-arginine
  作者：Ryoji Kikumoto、Yoshikuni Tamao、Kazuo Ohkubo、Tohru Tezuka、Shinji Tonomura、Shosuke Okamoto、Akiko Hijikata

  DOI：10.1021/jm00186a003

  日期：1980.12

  N alpha-(arylsulfonyl)-L-arginine amide derivatives having carboxamide N-substituents with a carboxyl group was prepared and tested as inhibitors of the clotting activity of thrombin. The most inhibitory compounds were obtained when a carboxyl group was introduced into the carbon next to the amide nitrogen of N alpha-(arylsulfonyl)-L-arginine amide derivatives, e.g., N alpha-(arylsulfonyl)-L-arginyl-N-butyl-

  制备了一系列具有羧基羧基酰胺N-取代基的Nα-（芳基磺酰基）-L-精氨酸酰胺衍生物，并测试了它们作为凝血酶凝血活性的抑制剂。当在Nα-（芳基磺酰基）-L-精氨酸酰胺衍生物（例如Nα-（芳基磺酰基）-L-精氨酸-N-丁基）的酰胺氮旁的碳原子中引入羧基时，获得最具抑制性的化合物。 -，N-（甲氧基乙基）-或N-（四氢糠基）甘氨酸和4-烷基-1- [Nα-（芳基磺酰基）-L-精氨酰基] -2-哌啶甲酸，I50为1-3 X 10（ -7）M.
• 2-Aminopyrimidine Derivative
  申请人：Okamoto Yoshinori

  公开号：US20070265289A1

  公开（公告）日：2007-11-15

  The invention relates to a compound useful as remedies or preventives for IKK2-related inflammatory diseases or autoimmune diseases, or that is, a 2-aminopyrimidine derivative having a 2-hydroxyphenyl group at the 6-position thereof and having a saturated cyclic group that contains one nitrogen atom, such as piperidine, at the 4-position thereof. The pharmaceutical composition of the invention and the compound of the invention have an excellent antiinflammatory effect based on the IKK2-inhibitory effect thereof, and are therefore useful for remedies and preventives for inflammatory diseases and autoimmune diseases, especially for rheumatoid arthritis.

  本发明涉及一种化合物，可用作治疗或预防IKK2相关的炎症性疾病或自身免疫性疾病的药物，即在其6位具有2-羟基苯基基团并且在其4位具有含有一个氮原子的饱和环状基团（例如哌啶）的2-氨基嘧啶衍生物。本发明的制药组合物和该化合物具有出色的抗炎作用，基于其IKK2抑制作用，因此对于治疗和预防炎症性疾病和自身免疫性疾病特别是类风湿性关节炎非常有用。
• TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES
  申请人：AbbVie Inc.

  公开号：US20140080816A1

  公开（公告）日：2014-03-20

  The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT 2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT 2C receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT 2C receptor.

  本发明涉及三环喹啉和喹噁啉衍生物，以及含有这些化合物的药物组合物，它们的用途为5-HT2C受体的调节剂，特别是激动剂或部分激动剂，用于制备用于预防或治疗对5-HT2C受体调节有反应的病症和疾病的药物，以及用于预防或治疗对5-HT2C受体调节有反应的病症和疾病的方法。
• 2-AMINOPYRIDINE DERIVATIVE
  申请人：Astellas Pharma Inc.

  公开号：EP1736472A1

  公开（公告）日：2006-12-27

  The invention relates to a compound useful as remedies or preventives for IKK2-related inflammatory diseases or autoimmune diseases, or that is, a 2-aminopyrimidine derivative having a 2-hydroxyphenyl group at the 6-position thereof and having a saturated cyclic group that contains one nitrogen atom, such as piperidine, at the 4-position thereof. The pharmaceutical composition of the invention and the compound of the invention have an excellent antiinflammatory effect based on the IKK2-inhibitory effect thereof, and are therefore useful for remedies and preventives for inflammatory diseases and autoimmune diseases, especially for rheumatoid arthritis.

  本发明涉及一种可用于治疗或预防与IKK2相关的炎症性疾病或自身免疫性疾病的化合物，或者说是一种2-氨基嘧啶衍生物，其6位上具有2-羟基苯基，4位上具有含有一个氮原子的饱和环状基团，如哌啶。本发明的药物组合物和本发明的化合物基于其对 IKK2 的抑制作用，具有极佳的抗炎效果，因此可用于炎症性疾病和自身免疫性疾病，尤其是类风湿性关节炎的治疗和预防。
• Tricyclic quinoline and quinoxaline derivatives
  申请人：AbbVie Deutschland GmbH & Co. KG

  公开号：US10118926B2

  公开（公告）日：2018-11-06

  The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor.

  本发明涉及三环喹啉和喹喔啉衍生物，涉及含有此类化合物的药物组合物，涉及它们作为 5-HT2C 受体调节剂（尤其是激动剂或部分激动剂）的用途，涉及它们用于制备预防或治疗对 5-HT2C 受体调节有反应的病症和紊乱的药物，还涉及一种预防或治疗对 5-HT2C 受体调节有反应的病症和紊乱的方法。